Do you want to read an article? Please log in or register.
Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1
Asthma
RECOMMENDED
Related content
Asthma
A novel endpoint for exacerbations in asthma to accelerate clinical development: a post-hoc analysis of randomised controlled trials
Urol Oncol.
Fuhlbrigge AL, Bengtsson T,
Peterson S, Jauhiainen A, Eriksson G, Da Silva CA, Johnson A, Sethi T, Locantore N, Tal-Singer R, Fagerås M
doi: 10.1016/j.urolonc.2017.04.010.
Asthma
Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials
Lancet Respir Med.
Panettieri R, Sjöbring U,
Péterffy AM, Wessman P, Bowen K, Piper E, Colice G, Brightling Ch
doi: 10.1016/
RECOMMENDED
Asthma
Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trials
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Res
Lemiere C, Taillé C, Lee JK, Smith SG, Mallett S, Albers FC, Bradford ES, Yancey SW, Liu MC
doi: 10.1186/s12931-021-01767-z
RECOMMENDED
COPD
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Rabe KF, Halpin DMG, Han MK, Miravitlles M, Singh D, Grönke L, Voß F, Martinez FJ
doi: 10.1186/s12931-020-01431-y.
Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial
Read the comment: Effectiveness trials in asthma: time to SaLSA? >>>
doi: 10.1016/
COMMENTED
Asthma
Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
JAMA.
Forno E, Bacharier LB, Phipatanakul W, Guilbert TW, Cabana MD, Ross K, Covar R, Gern JE, Rosser FJ, Blatter J, Durrani S, Han YY, Wisniewski SR, Celedón JC
doi: 10.1001/jama.2020.12384.
Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial
BMC Pulm Med.
Altman P, Wehbe L, Dederichs J, Guerin T, Ament B, Moronta MC, Pino AV, Goyal P
doi: 10.1186/s12890-018-0662-0.
Asthma
Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials
Lancet Respir Med.
Brightling CE, Gaga M, Inoue H, Li J, Maspero J, Wenzel S, Maitra S, Lawrence D, Brockhaus F, Lehmann T, Brindicci C, Knorr B, Bleecker ER
doi: 10.1016/S2213-2600(20)30412-4.
RECOMMENDED
Asthma
Unmet Needs in Severe Asthma Subtyping and Precision Medicine Trials: Bridging Clinical and Patient Perspectives
Am J Respir Crit Care Med.
Siddiqui S, Denlinger LC, Fowler SJ, Akuthota P, Shaw DE, Heaney LG, Brown L, Castro M, Winders TA, Kraft M, Wagers S, Peters MC, Pavord ID, Walker S, Jarjour NN
doi: 10.1164/rccm.